Article

Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities

Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Integrative Biology (Impact Factor: 4). 12/2010; 3(4):422-38. DOI: 10.1039/c0ib00083c
Source: PubMed

ABSTRACT Matrix metalloproteinases (MMPs) and A Disintegrin and Metalloproteinases (ADAMs) are two related protease families that play key roles in matrix remodeling and growth factor ligand shedding. Directly ascertaining the proteolytic activities of particular MMPs and ADAMs in physiological environments in a non-invasive, real-time, multiplex manner remains a challenge. This work describes Proteolytic Activity Matrix Analysis (PrAMA), an integrated experimental measurement and mathematical analysis framework for simultaneously determining the activities of particular enzymes in complex mixtures of MMPs and ADAMs. The PrAMA method interprets dynamic signals from panels of moderately specific FRET-based polypeptide protease substrates to deduce a profile of specific MMP and ADAM proteolytic activities. Deconvolution of signals from complex mixtures of proteases is accomplished using prior data on individual MMP/ADAM cleavage signatures for the substrate panel measured with purified enzymes. We first validate PrAMA inference using a compendium of roughly 4000 measurements involving known mixtures of purified enzymes and substrates, and then demonstrate application to the live-cell response of wildtype, ADAM10-/-, and ADAM17-/- fibroblasts to phorbol ester and ionomycin stimulation. Results indicate PrAMA can distinguish closely related enzymes from each other with high accuracy, even in the presence of unknown background proteolytic activity. PrAMA offers a valuable tool for applications ranging from live-cell in vitro assays to high-throughput inhibitor screening with complex enzyme mixtures. Moreover, our approach may extend to other families of proteases, such as caspases and cathepsins, that also can lack highly-specific substrates.

2 Followers
 · 
184 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This work presents the random sampling - high dimensional model representation (RS-HDMR) algorithm for identifying complex bionetwork structures from multivariate data. RS-HDMR describes network interactions through a hierarchy of input-output (IO) functions of increasing dimensionality. Sensitivity analysis based on the calculated RS-HDMR component functions provides a statistically interpretable measure of network interaction strength, and can be used to efficiently infer network structure. Advantages of RS-HDMR include the ability to capture nonlinear and cooperative realtionships among network components, the ability to handle both continuous and discrete relationships, the ability to be used as a high-dimensional IO model for quantitative property prediction, and favorable scalability with respect to the number of variables. To demonstrate, RS-HDMR was applied to experimental data measuring the single-cell response of a protein-protein signaling network to various perturbations. The resultant analysis identified the network structure comparable to that reported in the literature and to the results from a previous Bayesian network (BN) analysis. The IO model also revealed several nonlinear feedback and cooperative mechanisms that were unidentified through BN analysis.
    Conference proceedings: ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 01/2009; 2009:6412-5. DOI:10.1109/IEMBS.2009.5333798
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We introduce an integrated microfluidic device consisting of a biomolecule concentrator and a microdroplet generator, which enhances the limited sensitivity of low-abundance enzyme assays by concentrating biomolecules before encapsulating them into droplet microreactors. We used this platform to detect ultralow levels of matrix metalloproteinases (MMPs) from diluted cellular supernatant and showed that it significantly (~10-fold) reduced the time required to complete the assay and the sample volume used.
    Journal of the American Chemical Society 06/2011; 133(27):10368-71. DOI:10.1021/ja2036628 · 11.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Prodomains of A disintegrin and metalloproteinase (ADAM) metallopeptidases can act as highly specific intra- and intermolecular inhibitors of ADAM catalytic activity. The mouse ADAM9 prodomain (proA9; amino acids 24-204), expressed and characterized from Escherichia coli, is a competitive inhibitor of human ADAM9 catalytic/disintegrin domain with an overall inhibition constant of 280 ± 34 nM and high specificity toward ADAM9. In SY5Y neuroblastoma cells overexpressing amyloid precursor protein, proA9 treatment reduces the amount of endogenous ADAM10 enzyme in the medium while increasing membrane-bound ADAM10, as shown both by Western and activity assays with selective fluorescent peptide substrates using proteolytic activity matrix analysis. An increase in membrane-bound ADAM10 generates higher levels of soluble amyloid precursor protein α in the medium, whereas soluble amyloid precursor protein β levels are decreased, demonstrating that inhibition of ADAM9 increases α-secretase activity on the cell membrane. Quantification of physiological ADAM10 substrates by a proteomic approach revealed that substrates, such as epidermal growth factor (EGF), HER2, osteoactivin, and CD40-ligand, are increased in the medium of BT474 breast tumor cells that were incubated with proA9, demonstrating that the regulation of ADAM10 by ADAM9 applies for many ADAM10 substrates. Taken together, our results demonstrate that ADAM10 activity is regulated by inhibition of ADAM9, and this regulation may be used to control shedding of amyloid precursor protein by enhancing α-secretase activity, a key regulatory step in the etiology of Alzheimer disease.
    Journal of Biological Chemistry 09/2011; 286(47):40443-51. DOI:10.1074/jbc.M111.280495 · 4.60 Impact Factor

Preview

Download
6 Downloads
Available from